Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $119.50
- Average 1Y price target
- $143.45+20.04%
- Agreement
- Fair
Analysts agreement range is spread 15% to 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall3
- DCF3
- Return on equity5
- Return on assets5
- Debt / equity2
- P/E1
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 9 | $138.78 |
| Last quarter | 10 | $137.10 |
| Last year | 31 | $150.16 |
| All time | 86 | $139.88 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 23, 2026 | UBS | maintain | Neutral | Neutral |
| Oct 23, 2026 | Piper Sandler | maintain | Neutral | Neutral |
| Oct 23, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Oct 23, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Oct 19, 2026 | Piper Sandler | maintain | Neutral | Neutral |
| Oct 13, 2026 | UBS | maintain | Neutral | Neutral |
| Oct 12, 2026 | TD Cowen | maintain | Buy | Buy |
| Oct 8, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Aug 27, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Jul 30, 2026 | Argus Research | maintain | Buy | Buy |
| Jul 24, 2026 | TD Cowen | maintain | Buy | Buy |
| Jul 24, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jul 24, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Jul 24, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Jul 24, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Jul 17, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Jul 16, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Jul 13, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jul 13, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Jul 9, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Jul 9, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| May 18, 2026 | TD Cowen | maintain | Buy | Buy |
| Apr 27, 2026 | Piper Sandler | maintain | Neutral | Neutral |
| Apr 24, 2026 | TD Cowen | maintain | Buy | Buy |
| Apr 24, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Apr 24, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Apr 22, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Apr 21, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Apr 21, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Apr 17, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Apr 13, 2026 | Oppenheimer | upgrade | Perform | Outperform |
| Apr 8, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Apr 7, 2026 | Piper Sandler | maintain | Neutral | Neutral |
| Apr 7, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Mar 24, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Mar 3, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Mar 2, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Feb 20, 2026 | UBS | maintain | Neutral | Neutral |
| Feb 2, 2026 | Piper Sandler | maintain | Neutral | Neutral |
| Jan 30, 2026 | TD Cowen | maintain | Buy | Buy |